Skip to search formSkip to main contentSkip to account menu

Quinlukast

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

VUFB19363

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
[Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
Solubility of the new antileukotrienic drug quinlukast (4-{[4-(2-quinolylmethoxy)phenyl]sulfanyl}benzoic acid) was determined in… 
2005
2005
Pharmacokinetics of radiolabelled quinlukast in rats.
2004
2004
Characterization of enzymes responsible for biotransformation of the new antileukotrienic drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes
The promising new drug quinlukast, 4‐(4‐(quinoline‐2′‐yl‐methoxy)phenylsulphanyl)benzoic acid (VÚFB 19363), is under… 
2004
2004
HPLC-radiometric determination of quinlukast in biological fluids.
2003
2003
Inhibition of aromatic amino acid decarboxylase by a group of new potential nonsteroidal anti-inflammatory drugs with antileukotrienic effects.
Possible in vitro inhibition of aromatic amino acid decarboxylase (AAD, EC 4.1.1.28) by a group of phenylsulfonylbenzoic acid… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)